Two-way crossover comparison of insulin glargine and insulin degludec in basal-bolus therapy using continuous glucose monitoring.
Phase of Trial: Phase II
Latest Information Update: 31 May 2018
Price : $35 *
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Diabetes insipidus; Diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 May 2018 Status changed from recruiting to completed.
- 20 Mar 2014 New trial record